PeptideDB

CNJ-294

CAS: 1029713-99-2 F: C22H15FN6O W: 398.39

CNJ-294 is an intermediate in the synthesis of Capmatinib (HY-13404) and a metabolite of Capmatinib (HY-13404).
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity CNJ-294 is an intermediate in the synthesis of Capmatinib (HY-13404) and a metabolite of Capmatinib (HY-13404)[1][2].
CAS 1029713-99-2
Formula C22H15FN6O
Molar Mass 398.39
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Qingquan Lian. Preparation method of carbamatinib. CN111825678 A. 2020-10-27. [2]. Glaenzel U, et al. Absorption, Distribution, Metabolism, and Excretion of Capmatinib (INC280) in Healthy Male Volunteers and In Vitro Aldehyde Oxidase Phenotyping of the Major Metabolite. Drug Metab Dispos. 2020 Oct;48(10):873-885.